The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C02 | Antihypertensives | |
| 3 | C02D | Arteriolar smooth muscle, agents acting on | |
| 4 | C02DB | Hydrazinophthalazine derivatives |
| Code | Title | |
|---|---|---|
| C02DB01 | Dihydralazine | |
| C02DB02 | Hydralazine | |
| C02DB03 | Endralazine | |
| C02DB04 | Cadralazine |
| Active Ingredient | Description | |
|---|---|---|
| Dihydralazine |
Dihydralazine is a member of phthalazines. |
|
| Hydralazine |
Hydralazine is a direct acting vasodilator which exerts its effects principally on the arterioles. Its precise mode of action is not known. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| APRESOLINE Solution for injection | Health Products and Food Branch (CA) | MPI, CA: SPM |